|
IT1110460B
(it)
*
|
1977-03-02 |
1985-12-23 |
Ciba Geigy Ag |
Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
|
|
FR2639942B1
(fr)
*
|
1988-12-02 |
1991-03-29 |
Sanofi Sa |
Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
|
|
US5665756A
(en)
*
|
1994-08-03 |
1997-09-09 |
Hoechst Marion Roussel, Inc. |
Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
|
|
US6548084B2
(en)
*
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
|
WO1997006792A1
(en)
*
|
1995-08-16 |
1997-02-27 |
Eli Lilly And Company |
Potentiation of serotonin response
|
|
IN182588B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
1998-05-12 |
1999-05-08 |
Sun Pharmaceutical Ind Ltd |
|
|
IE990406A1
(en)
|
1999-05-20 |
2000-12-27 |
Elan Corp Plc |
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
|
|
IN186677B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
1999-11-12 |
2001-10-20 |
Sun Pharmaceutical Ind Ltd |
|
|
WO2001078721A1
(en)
*
|
2000-04-13 |
2001-10-25 |
Mayo Foundation For Medical Education And Research |
Aβ42 LOWERING AGENTS
|
|
US20080021085A1
(en)
*
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
AU5565401A
(en)
*
|
2000-04-24 |
2001-11-07 |
Aryx Therapeutics |
Materials and methods for the treatment of depression
|
|
US7256191B2
(en)
*
|
2000-04-24 |
2007-08-14 |
Aryx Therapeutics |
Materials and methods for the treatment of depression
|
|
CN1606554B
(zh)
*
|
2001-10-12 |
2013-03-20 |
阿泽范药品公司 |
β-内酰胺后叶加压素V1a拮抗剂
|
|
EP2316468A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
|
WO2004071431A2
(en)
*
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
|
US20050042284A1
(en)
*
|
2003-07-11 |
2005-02-24 |
Myriad Genetics, Incorporated |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
|
|
KR100828218B1
(ko)
|
2003-09-12 |
2008-05-07 |
화이자 인코포레이티드 |
알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물
|
|
CA2547283C
(en)
*
|
2003-11-26 |
2010-11-09 |
Pfizer Products Inc. |
Aminopyrazole derivatives as gsk-3 inhibitors
|
|
JP5646126B2
(ja)
|
2003-12-11 |
2014-12-24 |
サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
|
|
US20070293538A1
(en)
*
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
|
WO2005102366A2
(en)
*
|
2004-04-19 |
2005-11-03 |
Philip Maxwell Satow |
Lithium combinations, and uses related thereto
|
|
EP1745180A1
(en)
*
|
2004-04-29 |
2007-01-24 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
|
BRPI0514303A
(pt)
*
|
2004-08-11 |
2008-06-10 |
Myriad Genetics Inc |
composição farmacêutica e método para tratar distúrbios neurodegenerativos
|
|
JP2008534504A
(ja)
|
2005-03-22 |
2008-08-28 |
アゼヴァン ファーマスーティカルズ，インコーポレイテッド |
月経前障害を治療するためのβラクタミルアルカン酸
|
|
WO2006116170A1
(en)
*
|
2005-04-22 |
2006-11-02 |
Wyeth |
Dihydrobenzofuran derivatives and uses thereof
|
|
GT200600164A
(es)
|
2005-04-22 |
2007-03-14 |
|
Derivados de dihidrobenzofuranos y usos de los mismos
|
|
BRPI0610785A2
(pt)
*
|
2005-04-22 |
2016-09-13 |
Wyeth Corp |
polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição
|
|
CA2605554A1
(en)
|
2005-04-22 |
2006-11-02 |
Wyeth |
Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
|
|
JP2009500043A
(ja)
*
|
2005-07-08 |
2009-01-08 |
ブレインセルス，インコーポレイティド |
神経新生を調節する薬剤及び条件を同定する方法
|
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
|
PL1910346T3
(pl)
*
|
2005-07-19 |
2019-09-30 |
Azevan Pharmaceuticals, Inc. |
Beta-laktamowy antagonista wazopresyny fenyloalaniny, cysteiny i seryny
|
|
EP1909777A2
(en)
*
|
2005-07-22 |
2008-04-16 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
|
CA2625153A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
JP2009513672A
(ja)
|
2005-10-31 |
2009-04-02 |
ブレインセルス，インコーポレイティド |
神経発生のｇａｂａ受容体媒介調節
|
|
FR2912057B1
(fr)
*
|
2007-02-07 |
2009-04-17 |
Sanofi Aventis Sa |
Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
EP1998773A2
(en)
*
|
2006-03-24 |
2008-12-10 |
Wyeth a Corporation of the State of Delaware |
New therapeutic combinations for the treatment of depression
|
|
JP4615470B2
(ja)
*
|
2006-03-29 |
2011-01-19 |
卓郎 簑和田 |
大脳の認知力を用いた疾患治療・予防の方法および医薬
|
|
JP2009536667A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス，インコーポレイティド |
５ｈｔ受容体介在性の神経新生
|
|
US7858611B2
(en)
*
|
2006-05-09 |
2010-12-28 |
Braincells Inc. |
Neurogenesis by modulating angiotensin
|
|
JP2009536669A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス，インコーポレイティド |
アンジオテンシン調節による神経新生
|
|
WO2008006099A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
|
TW200817003A
(en)
*
|
2006-07-31 |
2008-04-16 |
Sanofi Aventis |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100016274A1
(en)
*
|
2006-09-14 |
2010-01-21 |
Koppel Gary A |
Beta-lactam cannabinoid receptor modulators
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
WO2008083204A2
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc. |
Modulation of neurogenesis by melatoninergic ligands
|
|
WO2008086483A2
(en)
*
|
2007-01-11 |
2008-07-17 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
|
WO2009128058A1
(en)
|
2008-04-18 |
2009-10-22 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al |
Psycho-pharmaceuticals
|
|
US20100092479A1
(en)
*
|
2008-08-18 |
2010-04-15 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
WO2011050198A1
(en)
|
2009-10-23 |
2011-04-28 |
Janssen Pharmaceutica Nv |
Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
|
|
CA2783699C
(en)
|
2009-12-08 |
2019-01-15 |
Case Western Reserve University |
Primary amine compounds for treating ocular disorders
|
|
CN107007596A
(zh)
|
2010-07-01 |
2017-08-04 |
阿泽凡药物公司 |
用于治疗创伤后应激障碍的方法
|
|
MX2013010598A
(es)
|
2011-03-17 |
2014-01-08 |
Lupin Ltd |
Composiciones farmaceuticas de liberacion controlada de inhibidor de recaptacion de serotonina selectivo.
|
|
KR101427221B1
(ko)
*
|
2012-08-29 |
2014-08-13 |
주식회사 에스텍파마 |
플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
|
|
WO2014178064A2
(en)
*
|
2013-04-03 |
2014-11-06 |
Zcl Chemicals Limited |
"an improved process for the preparation of fluvoxamine maleate"
|
|
HRP20210114T1
(hr)
|
2014-02-07 |
2021-04-16 |
Támogatott Kutatócsoportok Irodája |
Nova primjena spoja agonista sigma-1 receptora
|
|
PL3122743T3
(pl)
|
2014-03-28 |
2023-05-02 |
Azevan Pharmaceuticals, Inc. |
Kompozycje i sposoby leczenia chorób neurodegeneracyjnych
|
|
JP7066622B2
(ja)
*
|
2016-03-10 |
2022-05-13 |
ヤンセン ファーマシューティカ エヌ．ベー． |
オレキシン－２受容体アンタゴニストを用いてうつ病を治療する方法
|
|
MA46898A
(fr)
|
2016-11-24 |
2019-10-02 |
Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag |
Compositions pour la conservation d'organes
|
|
AU2018333051B2
(en)
|
2017-09-15 |
2024-03-21 |
Azevan Pharmaceuticals, Inc. |
Compositions and methods for treating brain injury
|
|
CA3145388A1
(en)
|
2019-07-19 |
2021-01-28 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|